Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.Ozempic, Mounjaro, and other glucagon-like peptide-1 medications, otherwise known as GLP-1s, are changing how Americans shop for groceries. In early January, Food & Wine published a story about how food companies are releasing all-new products or reimagining the marketing of old ones to appeal to more GLP-1 users who may be looking for specific nutrition needs like high-protein, high-fiber foods. In that story, we mentioned one tiny but important research paper by Cornell University that showed that households with at least one GLP-1...